Rubicon Research

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
1,272.25
-42.15 (-3.21%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 20.15 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Rubicon Research
Acutaas Chemical
Neuland Labs.
Granules India
Sai Life
Natco Pharma
ERIS Lifescience
Astrazeneca Phar
Piramal Pharma
Pfizer
OneSource Speci.

Why is Rubicon Research Ltd ?

1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
  • Healthy long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 0%
  • Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.78 times
2
With a growth in Net Profit of 88.33%, the company declared Outstanding results in Mar 26
  • OPERATING PROFIT TO INTEREST(Q) Highest at 11.46 times
  • PBDIT(Q) Highest at Rs 118.71 cr.
  • PBT LESS OI(Q) Highest at Rs 96.08 cr.
3
Majority shareholders : Promoters
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Rubicon Research should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.10
Debt to EBITDA (avg)
1.50
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.16
Tax Ratio
23.02%
Dividend Payout Ratio
0.23%
Pledged Shares
0
Institutional Holding
17.55%
ROCE (avg)
25.58%
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
84
Industry P/E
33
Price to Book Value
15.99
EV to EBIT
57.96
EV to EBITDA
51.41
EV to Capital Employed
16.41
EV to Sales
11.73
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
28.31%
ROE (Latest)
19.14%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
Bollinger Bands
Bullish
KST
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

33What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 11.46 times

PBDIT(Q)

Highest at Rs 118.71 cr.

PBT LESS OI(Q)

Highest at Rs 96.08 cr.

PAT(Q)

Highest at Rs 76.79 cr.

NET SALES(Q)

Highest at Rs 513.92 cr

OPERATING PROFIT TO NET SALES(Q)

Highest at 23.10%

EPS(Q)

Highest at Rs 4.65

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Rubicon Research

Operating Profit to Interest - Quarterly
Highest at 11.46 times and Grown
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Operating Profit (PBDIT) - Quarterly
Highest at Rs 118.71 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 96.08 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 96.08 cr has Grown at 43.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 66.93 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 76.79 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 76.79 cr has Grown at 49.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 51.55 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 513.92 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 513.92 cr has Grown at 28.6% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 399.55 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 23.10%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Earnings per Share (EPS) - Quarterly
Highest at Rs 4.65
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)